California Public Employees Retirement System’s Ocular Therapeutix OCUL Stock Holding History

California Public Employees Retirement System’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-123,000	Closed	-$2.02M	–	2478
2021 Q1	$2.02M	Sell	123,000 -14,381	-10%	-$277K	﹤0.01%	2014
2020 Q4	$2.84M	Buy	137,381 +493	+0.4%	+$7.32K	﹤0.01%	1783
2020 Q3	$1.04M	Buy	136,888 +23,415	+21%	+$194K	﹤0.01%	2257
2020 Q2	$945K	Buy	113,473 +83,873	+283%	+$556K	﹤0.01%	2284
2020 Q1	$147K	Hold	29,600	–	–	﹤0.01%	2983
2019 Q4	$117K	Buy	+29,600	New	+$103K	﹤0.01%	3255

Other funds holding OCUL

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

California Public Employees Retirement System's OCUL Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Ocular Therapeutix (OCUL) in Q2 2021, closing a stake of 123,000 shares — an estimated $2.02M sold.

California Public Employees Retirement System first reported a position in OCUL in Q4 2019 and held it in 6 quarters. The position peaked at $2.84M in Q4 2020. 149 funds tracked by Wall St. Rank hold OCUL as of Q2 2021.

California Public Employees Retirement System reported no remaining Ocular Therapeutix position as of Q2 2021 after selling out during the quarter.
California Public Employees Retirement System sold 123,000 Ocular Therapeutix shares in Q2 2021, an estimated $2.02M.
California Public Employees Retirement System first reported a position in Ocular Therapeutix in Q4 2019 and held it in 6 quarters.
California Public Employees Retirement System's Ocular Therapeutix position peaked at $2.84M in Q4 2020.
149 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.